Uric acid to albumin ratio as a novel predictor for coronary slow flow phenomenon in patients with chronic coronary syndrome and non-obstructive coronary arteries
The plasma uric acid to albumin ratio (UAR) is considered as a novel indicator for Inflammation. However, the association between UAR and coronary slow flow phenomenon (CSFP) remains unclear. A total of 1328 individuals with chronic coronary syndrome (CCS) receiving coronary angiography (CAG) and fo...
Saved in:
Published in | BMC cardiovascular disorders Vol. 24; no. 1; pp. 358 - 7 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
England
BioMed Central Ltd
13.07.2024
BioMed Central BMC |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The plasma uric acid to albumin ratio (UAR) is considered as a novel indicator for Inflammation. However, the association between UAR and coronary slow flow phenomenon (CSFP) remains unclear.
A total of 1328 individuals with chronic coronary syndrome (CCS) receiving coronary angiography (CAG) and found no obvious obstructive stenosis (< 40%) were included in this study. 79 individuals developed CSFP and were divided into CSFP group. The 1:2 age-matched patients with normal coronary blood flow were allocated to the control group (n = 158). The clinical characteristics, laboratory parameters including uric acid, albumin ratio, UAR and the angiographic characteristics were compared between the two groups.
Patients with CSFP had a higher level of uric acid (392.3 ± 85.3 vs. 273.8 ± 71.5, P < 0.001), UAR (10.7 ± 2.2 vs. 7.2 ± 1.9, P < 0.001), but a lower level of plasma albumin (36.9 ± 4.2 vs. 38.5 ± 3.6, P = 0.003). Moreover, UAR increased as the numbers of vessels involved in CSFP increased. The logistic regression analysis demonstrated that UAR was independent predictors for CSFP. The Receiver operating characteristic (ROC) curve analysis showed that when UAR was more than 7.9, the AUC was 0.883 (95% CI: 0.840-0.927, p < 0.001), with the sensitivity and specificity were 78.2% and 88.2% respectively.
Combined uric acid with plasma albumin, UAR could serve as an independent predictor for CSFP. |
---|---|
AbstractList | The plasma uric acid to albumin ratio (UAR) is considered as a novel indicator for Inflammation. However, the association between UAR and coronary slow flow phenomenon (CSFP) remains unclear.BACKGROUNDThe plasma uric acid to albumin ratio (UAR) is considered as a novel indicator for Inflammation. However, the association between UAR and coronary slow flow phenomenon (CSFP) remains unclear.A total of 1328 individuals with chronic coronary syndrome (CCS) receiving coronary angiography (CAG) and found no obvious obstructive stenosis (< 40%) were included in this study. 79 individuals developed CSFP and were divided into CSFP group. The 1:2 age-matched patients with normal coronary blood flow were allocated to the control group (n = 158). The clinical characteristics, laboratory parameters including uric acid, albumin ratio, UAR and the angiographic characteristics were compared between the two groups.METHODSA total of 1328 individuals with chronic coronary syndrome (CCS) receiving coronary angiography (CAG) and found no obvious obstructive stenosis (< 40%) were included in this study. 79 individuals developed CSFP and were divided into CSFP group. The 1:2 age-matched patients with normal coronary blood flow were allocated to the control group (n = 158). The clinical characteristics, laboratory parameters including uric acid, albumin ratio, UAR and the angiographic characteristics were compared between the two groups.Patients with CSFP had a higher level of uric acid (392.3 ± 85.3 vs. 273.8 ± 71.5, P < 0.001), UAR (10.7 ± 2.2 vs. 7.2 ± 1.9, P < 0.001), but a lower level of plasma albumin (36.9 ± 4.2 vs. 38.5 ± 3.6, P = 0.003). Moreover, UAR increased as the numbers of vessels involved in CSFP increased. The logistic regression analysis demonstrated that UAR was independent predictors for CSFP. The Receiver operating characteristic (ROC) curve analysis showed that when UAR was more than 7.9, the AUC was 0.883 (95% CI: 0.840-0.927, p < 0.001), with the sensitivity and specificity were 78.2% and 88.2% respectively.RESULTSPatients with CSFP had a higher level of uric acid (392.3 ± 85.3 vs. 273.8 ± 71.5, P < 0.001), UAR (10.7 ± 2.2 vs. 7.2 ± 1.9, P < 0.001), but a lower level of plasma albumin (36.9 ± 4.2 vs. 38.5 ± 3.6, P = 0.003). Moreover, UAR increased as the numbers of vessels involved in CSFP increased. The logistic regression analysis demonstrated that UAR was independent predictors for CSFP. The Receiver operating characteristic (ROC) curve analysis showed that when UAR was more than 7.9, the AUC was 0.883 (95% CI: 0.840-0.927, p < 0.001), with the sensitivity and specificity were 78.2% and 88.2% respectively.Combined uric acid with plasma albumin, UAR could serve as an independent predictor for CSFP.CONCLUSIONCombined uric acid with plasma albumin, UAR could serve as an independent predictor for CSFP. Abstract Background The plasma uric acid to albumin ratio (UAR) is considered as a novel indicator for Inflammation. However, the association between UAR and coronary slow flow phenomenon (CSFP) remains unclear. Methods A total of 1328 individuals with chronic coronary syndrome (CCS) receiving coronary angiography (CAG) and found no obvious obstructive stenosis (< 40%) were included in this study. 79 individuals developed CSFP and were divided into CSFP group. The 1:2 age-matched patients with normal coronary blood flow were allocated to the control group (n = 158). The clinical characteristics, laboratory parameters including uric acid, albumin ratio, UAR and the angiographic characteristics were compared between the two groups. Results Patients with CSFP had a higher level of uric acid (392.3 ± 85.3 vs. 273.8 ± 71.5, P < 0.001), UAR (10.7 ± 2.2 vs. 7.2 ± 1.9, P < 0.001), but a lower level of plasma albumin (36.9 ± 4.2 vs. 38.5 ± 3.6, P = 0.003). Moreover, UAR increased as the numbers of vessels involved in CSFP increased. The logistic regression analysis demonstrated that UAR was independent predictors for CSFP. The Receiver operating characteristic (ROC) curve analysis showed that when UAR was more than 7.9, the AUC was 0.883 (95% CI: 0.840–0.927, p < 0.001), with the sensitivity and specificity were 78.2% and 88.2% respectively. Conclusion Combined uric acid with plasma albumin, UAR could serve as an independent predictor for CSFP. The plasma uric acid to albumin ratio (UAR) is considered as a novel indicator for Inflammation. However, the association between UAR and coronary slow flow phenomenon (CSFP) remains unclear. A total of 1328 individuals with chronic coronary syndrome (CCS) receiving coronary angiography (CAG) and found no obvious obstructive stenosis (< 40%) were included in this study. 79 individuals developed CSFP and were divided into CSFP group. The 1:2 age-matched patients with normal coronary blood flow were allocated to the control group (n = 158). The clinical characteristics, laboratory parameters including uric acid, albumin ratio, UAR and the angiographic characteristics were compared between the two groups. Combined uric acid with plasma albumin, UAR could serve as an independent predictor for CSFP. BackgroundThe plasma uric acid to albumin ratio (UAR) is considered as a novel indicator for Inflammation. However, the association between UAR and coronary slow flow phenomenon (CSFP) remains unclear.MethodsA total of 1328 individuals with chronic coronary syndrome (CCS) receiving coronary angiography (CAG) and found no obvious obstructive stenosis (< 40%) were included in this study. 79 individuals developed CSFP and were divided into CSFP group. The 1:2 age-matched patients with normal coronary blood flow were allocated to the control group (n = 158). The clinical characteristics, laboratory parameters including uric acid, albumin ratio, UAR and the angiographic characteristics were compared between the two groups.ResultsPatients with CSFP had a higher level of uric acid (392.3 ± 85.3 vs. 273.8 ± 71.5, P < 0.001), UAR (10.7 ± 2.2 vs. 7.2 ± 1.9, P < 0.001), but a lower level of plasma albumin (36.9 ± 4.2 vs. 38.5 ± 3.6, P = 0.003). Moreover, UAR increased as the numbers of vessels involved in CSFP increased. The logistic regression analysis demonstrated that UAR was independent predictors for CSFP. The Receiver operating characteristic (ROC) curve analysis showed that when UAR was more than 7.9, the AUC was 0.883 (95% CI: 0.840–0.927, p < 0.001), with the sensitivity and specificity were 78.2% and 88.2% respectively.ConclusionCombined uric acid with plasma albumin, UAR could serve as an independent predictor for CSFP. Background The plasma uric acid to albumin ratio (UAR) is considered as a novel indicator for Inflammation. However, the association between UAR and coronary slow flow phenomenon (CSFP) remains unclear. Methods A total of 1328 individuals with chronic coronary syndrome (CCS) receiving coronary angiography (CAG) and found no obvious obstructive stenosis (< 40%) were included in this study. 79 individuals developed CSFP and were divided into CSFP group. The 1:2 age-matched patients with normal coronary blood flow were allocated to the control group (n = 158). The clinical characteristics, laboratory parameters including uric acid, albumin ratio, UAR and the angiographic characteristics were compared between the two groups. Results Patients with CSFP had a higher level of uric acid (392.3 [+ or -] 85.3 vs. 273.8 [+ or -] 71.5, P < 0.001), UAR (10.7 [+ or -] 2.2 vs. 7.2 [+ or -] 1.9, P < 0.001), but a lower level of plasma albumin (36.9 [+ or -] 4.2 vs. 38.5 [+ or -] 3.6, P = 0.003). Moreover, UAR increased as the numbers of vessels involved in CSFP increased. The logistic regression analysis demonstrated that UAR was independent predictors for CSFP. The Receiver operating characteristic (ROC) curve analysis showed that when UAR was more than 7.9, the AUC was 0.883 (95% CI: 0.840-0.927, p < 0.001), with the sensitivity and specificity were 78.2% and 88.2% respectively. Conclusion Combined uric acid with plasma albumin, UAR could serve as an independent predictor for CSFP. Keywords: Uric acid to albumin ratio, Coronary slow flow phenomenon, Chronic coronary syndrome, Predictors, Coronary artery disease The plasma uric acid to albumin ratio (UAR) is considered as a novel indicator for Inflammation. However, the association between UAR and coronary slow flow phenomenon (CSFP) remains unclear. A total of 1328 individuals with chronic coronary syndrome (CCS) receiving coronary angiography (CAG) and found no obvious obstructive stenosis (< 40%) were included in this study. 79 individuals developed CSFP and were divided into CSFP group. The 1:2 age-matched patients with normal coronary blood flow were allocated to the control group (n = 158). The clinical characteristics, laboratory parameters including uric acid, albumin ratio, UAR and the angiographic characteristics were compared between the two groups. Patients with CSFP had a higher level of uric acid (392.3 ± 85.3 vs. 273.8 ± 71.5, P < 0.001), UAR (10.7 ± 2.2 vs. 7.2 ± 1.9, P < 0.001), but a lower level of plasma albumin (36.9 ± 4.2 vs. 38.5 ± 3.6, P = 0.003). Moreover, UAR increased as the numbers of vessels involved in CSFP increased. The logistic regression analysis demonstrated that UAR was independent predictors for CSFP. The Receiver operating characteristic (ROC) curve analysis showed that when UAR was more than 7.9, the AUC was 0.883 (95% CI: 0.840-0.927, p < 0.001), with the sensitivity and specificity were 78.2% and 88.2% respectively. Combined uric acid with plasma albumin, UAR could serve as an independent predictor for CSFP. |
ArticleNumber | 358 |
Audience | Academic |
Author | Zhang, Xiao-jiao Wang, Cheng-fu Luan, Bo Hou, Ai-jie Li, Jia-jin |
Author_xml | – sequence: 1 givenname: Xiao-jiao surname: Zhang fullname: Zhang, Xiao-jiao – sequence: 2 givenname: Ai-jie surname: Hou fullname: Hou, Ai-jie – sequence: 3 givenname: Bo surname: Luan fullname: Luan, Bo – sequence: 4 givenname: Cheng-fu surname: Wang fullname: Wang, Cheng-fu – sequence: 5 givenname: Jia-jin surname: Li fullname: Li, Jia-jin |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/39003493$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kstu3CAUhq0qVXNpX6CLCqmbbpyCwTYso6iXSJG6adYIHyBDZMMUmER5nT5pz2SSThtVFeKq7_8PiP-4OYgpuqZ5y-gpY3L4WFgnx66lnWipwNb2L5ojJkbWdt3ADv5YHzbHpdxQykZJ1avmkCtKuVD8qPl5lQMQA8GSmoiZp80SIsmmBtwVYkhMt24m6-xsgJoy8dgh5RRNvidlTnfEb4f1ysW0YI8E9WvUu1gLuQt1RWCFOFbZy-6jzUgTEy0WiG2aSs0bqOHW7SmTq8vBldfNS2_m4t48zifN1edP38-_tpffvlycn1220FNZWzsBqGl00js_OA5UMmB0kkKAkEaOyo9UKuoGC3SYxDh55kB5Lqng_eQUP2kudr42mRu9zmHBW-hkgn44SPla45UCzE5z2xnLvLQcjGDWmpEpgKETvR2sUBS9Puy81jn92LhS9RIKuHk20aVN0ZyOSvWDoh2i75-hN2mTI74UKYVfrLhUe-raYP0QfarZwNZUn0nKumHgYkDq9B8UNuuWAJgeH_D8L8G7x-KbaXH296ufAoKA3AGQUynZeQ2hbtMR0TnMmlG9zaLeZVFjFvVDFnWP0u6Z9Mn9P6JfTbDisg |
CitedBy_id | crossref_primary_10_2147_IJGM_S481538 crossref_primary_10_1186_s12872_025_04507_z crossref_primary_10_2147_IJGM_S516108 |
Cites_doi | 10.1016/0735-1097(95)00088-L 10.1016/j.jjcc.2012.09.004 10.1177/00033197231161902 10.1177/00033197221110700 10.1159/000460239 10.1016/j.febslet.2008.04.057 10.1016/j.metabol.2017.06.006 10.1177/00033197221139685 10.1159/000336948 10.1002/hep.20720 10.1016/j.amjcard.2016.11.054 10.1016/j.numecd.2021.05.034 10.3390/jcm10204750 10.1532/hsf.2397 10.1016/j.ijcard.2017.04.003 10.5114/aoms.2015.51412 10.1016/j.cardfail.2011.02.010 10.1007/s11906-013-0344-5 10.1080/00365513.2022.2084698 10.1093/eurheartj/ehi879 10.1186/s12872-022-02798-0 10.1177/00033197211066362 10.3233/CH-2008-1079 10.1253/circj.CJ-12-0205 10.1038/s41392-022-00955-7 10.1056/NEJM199902113400607 10.1186/s12872-023-03579-z 10.3390/ijms24032960 10.1111/echo.14643 |
ContentType | Journal Article |
Copyright | 2024. The Author(s). COPYRIGHT 2024 BioMed Central Ltd. 2024. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
Copyright_xml | – notice: 2024. The Author(s). – notice: COPYRIGHT 2024 BioMed Central Ltd. – notice: 2024. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7QP 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. M0S M1P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 DOA |
DOI | 10.1186/s12872-024-04040-5 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Calcium & Calcified Tissue Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni) PML(ProQuest Medical Library) ProQuest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic Calcium & Calcified Tissue Abstracts ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic Publicly Available Content Database MEDLINE |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1471-2261 |
EndPage | 7 |
ExternalDocumentID | oai_doaj_org_article_3d2ad1f8d3ca41dda719cc6245d6d490 A801266346 39003493 10_1186_s12872_024_04040_5 |
Genre | Journal Article |
GeographicLocations | China |
GeographicLocations_xml | – name: China |
GroupedDBID | --- 0R~ 23N 2WC 53G 5VS 6J9 6PF 7X7 88E 8FI 8FJ AAFWJ AAJSJ AASML AAWTL AAYXX ABUWG ACGFO ACGFS ACIHN ACPRK ADBBV ADRAZ ADUKV AEAQA AENEX AFKRA AFPKN AHBYD AHMBA AHYZX ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C6C CCPQU CITATION CS3 DIK DU5 E3Z EBD EBLON EBS ECGQY EMB EMOBN F5P FYUFA GROUPED_DOAJ GX1 HMCUK HYE IAO IHR INH INR ITC KQ8 M1P M48 M~E O5R O5S OK1 OVT P2P PGMZT PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO RBZ RNS ROL RPM RSV SMD SOJ SV3 TR2 UKHRP W2D WOQ WOW XSB CGR CUY CVF ECM EIF NPM PJZUB PPXIY PMFND 3V. 7QP 7XB 8FK AZQEC DWQXO K9. PKEHL PQEST PQUKI PRINS 7X8 PUEGO |
ID | FETCH-LOGICAL-c508t-dbcc9b7e8fef6e3c081c10b844c48a879f70890e6dc06b47bf1ec9f380435be93 |
IEDL.DBID | M48 |
ISSN | 1471-2261 |
IngestDate | Wed Aug 27 01:32:22 EDT 2025 Thu Jul 10 21:59:58 EDT 2025 Sat Jul 26 02:43:41 EDT 2025 Tue Jun 17 22:08:02 EDT 2025 Tue Jun 10 21:06:58 EDT 2025 Mon Jul 21 05:39:33 EDT 2025 Tue Jul 01 02:38:11 EDT 2025 Thu Apr 24 23:12:40 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Uric acid to albumin ratio Coronary slow flow phenomenon Chronic coronary syndrome Coronary artery disease Predictors |
Language | English |
License | 2024. The Author(s). |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c508t-dbcc9b7e8fef6e3c081c10b844c48a879f70890e6dc06b47bf1ec9f380435be93 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
OpenAccessLink | https://www.proquest.com/docview/3091289389?pq-origsite=%requestingapplication% |
PMID | 39003493 |
PQID | 3091289389 |
PQPubID | 44077 |
PageCount | 7 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_3d2ad1f8d3ca41dda719cc6245d6d490 proquest_miscellaneous_3079956902 proquest_journals_3091289389 gale_infotracmisc_A801266346 gale_infotracacademiconefile_A801266346 pubmed_primary_39003493 crossref_citationtrail_10_1186_s12872_024_04040_5 crossref_primary_10_1186_s12872_024_04040_5 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2024-07-13 |
PublicationDateYYYYMMDD | 2024-07-13 |
PublicationDate_xml | – month: 07 year: 2024 text: 2024-07-13 day: 13 |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: London |
PublicationTitle | BMC cardiovascular disorders |
PublicationTitleAlternate | BMC Cardiovasc Disord |
PublicationYear | 2024 |
Publisher | BioMed Central Ltd BioMed Central BMC |
Publisher_xml | – name: BioMed Central Ltd – name: BioMed Central – name: BMC |
References | G Genc Tapar (4040_CR5) 2020; 37 MC Leone (4040_CR18) 2008; 39 GJ Quinlan (4040_CR13) 2005; 41 C Gabay (4040_CR27) 1999; 340 M Roche (4040_CR14) 2008; 582 JF Beltrame (4040_CR1) 2012; 76 SG Nurkoç (4040_CR31) 2024; 75 H González-Pacheco (4040_CR24) 2017; 119 A Maloberti (4040_CR10) 2021; 10 Y Wang (4040_CR6) 2017; 138 SC Chien (4040_CR25) 2017; 241 Z Soltani (4040_CR11) 2013; 15 S Li (4040_CR17) 2022; 82 T Çınar (4040_CR30) 2023; 74 XT Dai (4040_CR3) 2022; 22 AR Aroor (4040_CR8) 2017; 74 M Selçuk (4040_CR29) 2022; 74 IM Caglar (4040_CR23) 2016; 12 S Kalkan (4040_CR15) 2022; 73 GM Lin (4040_CR21) 2013; 61 P Kong (4040_CR12) 2022; 7 S Arques (4040_CR26) 2011; 17 D Yalcinkaya (4040_CR28) 2024; 75 C Ruggiero (4040_CR9) 2006; 27 EÖ Çakmak (4040_CR16) 2021; 8 E Russo (4040_CR7) 2023; 24 Y Xing (4040_CR20) 2019; 22 SB Yang (4040_CR2) 2023; 23 V Kopetz (4040_CR4) 2012; 121 GS Mintz (4040_CR19) 1995; 25 X Wang (4040_CR22) 2021; 31 |
References_xml | – volume: 8 start-page: 99 issue: 3–4 year: 2021 ident: 4040_CR16 publication-title: Pulse (Basel) – volume: 25 start-page: 1479 issue: 7 year: 1995 ident: 4040_CR19 publication-title: J Am Coll Cardiol doi: 10.1016/0735-1097(95)00088-L – volume: 61 start-page: 122 issue: 2 year: 2013 ident: 4040_CR21 publication-title: J Cardiol doi: 10.1016/j.jjcc.2012.09.004 – volume: 75 start-page: 386 issue: 4 year: 2024 ident: 4040_CR28 publication-title: Angiology doi: 10.1177/00033197231161902 – volume: 74 start-page: 381 issue: 4 year: 2023 ident: 4040_CR30 publication-title: Angiology doi: 10.1177/00033197221110700 – volume: 74 start-page: 156 issue: 3 year: 2022 ident: 4040_CR29 publication-title: Rev Invest Clin – volume: 138 start-page: 141 issue: 3 year: 2017 ident: 4040_CR6 publication-title: Cardiology doi: 10.1159/000460239 – volume: 582 start-page: 1783 issue: 13 year: 2008 ident: 4040_CR14 publication-title: FEBS Lett doi: 10.1016/j.febslet.2008.04.057 – volume: 74 start-page: 32 year: 2017 ident: 4040_CR8 publication-title: Metabolism doi: 10.1016/j.metabol.2017.06.006 – volume: 75 start-page: 72 issue: 1 year: 2024 ident: 4040_CR31 publication-title: Angiology doi: 10.1177/00033197221139685 – volume: 121 start-page: 197 issue: 3 year: 2012 ident: 4040_CR4 publication-title: Cardiology doi: 10.1159/000336948 – volume: 41 start-page: 1211 issue: 6 year: 2005 ident: 4040_CR13 publication-title: Hepatology doi: 10.1002/hep.20720 – volume: 119 start-page: 951 issue: 7 year: 2017 ident: 4040_CR24 publication-title: Am J Cardiol doi: 10.1016/j.amjcard.2016.11.054 – volume: 31 start-page: 2756 issue: 10 year: 2021 ident: 4040_CR22 publication-title: Nutr Metab Cardiovasc Dis doi: 10.1016/j.numecd.2021.05.034 – volume: 10 start-page: 4750 issue: 20 year: 2021 ident: 4040_CR10 publication-title: J Clin Med doi: 10.3390/jcm10204750 – volume: 22 start-page: E247 issue: 3 year: 2019 ident: 4040_CR20 publication-title: Heart Surg Forum doi: 10.1532/hsf.2397 – volume: 241 start-page: 1 year: 2017 ident: 4040_CR25 publication-title: Int J Cardiol doi: 10.1016/j.ijcard.2017.04.003 – volume: 12 start-page: 31 issue: 1 year: 2016 ident: 4040_CR23 publication-title: Arch Med Sci doi: 10.5114/aoms.2015.51412 – volume: 17 start-page: 451 issue: 6 year: 2011 ident: 4040_CR26 publication-title: J Card Fail doi: 10.1016/j.cardfail.2011.02.010 – volume: 15 start-page: 175 issue: 3 year: 2013 ident: 4040_CR11 publication-title: Curr Hypertens Rep doi: 10.1007/s11906-013-0344-5 – volume: 82 start-page: 304 issue: 4 year: 2022 ident: 4040_CR17 publication-title: Scand J Clin Lab Invest doi: 10.1080/00365513.2022.2084698 – volume: 27 start-page: 1174 issue: 10 year: 2006 ident: 4040_CR9 publication-title: Eur Heart J doi: 10.1093/eurheartj/ehi879 – volume: 22 start-page: 362 issue: 1 year: 2022 ident: 4040_CR3 publication-title: BMC Cardiovasc Disord doi: 10.1186/s12872-022-02798-0 – volume: 73 start-page: 461 issue: 5 year: 2022 ident: 4040_CR15 publication-title: Angiology doi: 10.1177/00033197211066362 – volume: 39 start-page: 185 issue: 1–4 year: 2008 ident: 4040_CR18 publication-title: Clin Hemorheol Microcirc doi: 10.3233/CH-2008-1079 – volume: 76 start-page: 818 issue: 4 year: 2012 ident: 4040_CR1 publication-title: Circulation Journal: Official J Japanese Circulation Soc doi: 10.1253/circj.CJ-12-0205 – volume: 7 start-page: 131 issue: 1 year: 2022 ident: 4040_CR12 publication-title: Signal Transduct Target Ther doi: 10.1038/s41392-022-00955-7 – volume: 340 start-page: 448 issue: 6 year: 1999 ident: 4040_CR27 publication-title: N Engl J Med doi: 10.1056/NEJM199902113400607 – volume: 23 start-page: 540 issue: 1 year: 2023 ident: 4040_CR2 publication-title: BMC Cardiovasc Disord doi: 10.1186/s12872-023-03579-z – volume: 24 start-page: 2960 issue: 3 year: 2023 ident: 4040_CR7 publication-title: Int J Mol Sci doi: 10.3390/ijms24032960 – volume: 37 start-page: 528 issue: 4 year: 2020 ident: 4040_CR5 publication-title: Echocardiography doi: 10.1111/echo.14643 |
SSID | ssj0017809 |
Score | 2.392311 |
Snippet | The plasma uric acid to albumin ratio (UAR) is considered as a novel indicator for Inflammation. However, the association between UAR and coronary slow flow... Background The plasma uric acid to albumin ratio (UAR) is considered as a novel indicator for Inflammation. However, the association between UAR and coronary... BackgroundThe plasma uric acid to albumin ratio (UAR) is considered as a novel indicator for Inflammation. However, the association between UAR and coronary... Abstract Background The plasma uric acid to albumin ratio (UAR) is considered as a novel indicator for Inflammation. However, the association between UAR and... |
SourceID | doaj proquest gale pubmed crossref |
SourceType | Open Website Aggregation Database Index Database Enrichment Source |
StartPage | 358 |
SubjectTerms | Aged Albumin Angina pectoris Angiography Atherosclerosis Biomarkers - blood Blood Blood flow Cardiovascular disease Case-Control Studies Cholesterol Chronic coronary syndrome Chronic Disease Complications and side effects Contrast agents Coronary Angiography Coronary artery Coronary artery disease Coronary Artery Disease - blood Coronary Artery Disease - diagnosis Coronary Artery Disease - diagnostic imaging Coronary Artery Disease - physiopathology Coronary Circulation Coronary heart disease Coronary slow flow phenomenon Coronary vessels Coronary Vessels - diagnostic imaging Coronary Vessels - physiopathology Diagnosis Female Health aspects Heart attacks Humans Hypertension Laboratories Logistics Male Measurement Medical examination Medical imaging Middle Aged No-Reflow Phenomenon - blood No-Reflow Phenomenon - diagnosis No-Reflow Phenomenon - diagnostic imaging No-Reflow Phenomenon - etiology No-Reflow Phenomenon - physiopathology Pathophysiology Plasma Predictive Value of Tests Predictors Regression analysis Retrospective Studies Risk Factors Serum Albumin, Human - analysis Stenosis Trinucleotide repeats Uric acid Uric Acid - blood Uric acid to albumin ratio |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3Ni9UwEA-yB_EifltdJYLgQcKmTZqP4youi7CefLC3kK_CwqNdtm9X_Hf8S51J8577FPTipYd2pk06k8xvmukvhLxNRtvBJM6Sh4MUIrDQ4hcxI4egjfBdqao8-6JOV_LzeX9-a6svrAlb6IGXF3ckUudTC7cT0cs2Ja9bG6PqZJ9UkrZk6xDztslUXT_QhtvtLzJGHc0wC-uOQTxi4LSSs34vDBW2_j_n5N-QZok4Jw_I_QoV6fHSxIfkTh4fkbtndTH8MfmxgjmM-niR6Gaipc74YqTFotTP1NNxuslrenmFGpBaU8CnNCJjgb_6Tuf19I0OeMAqL-RhmEYK-pVodab4hZbGhTv3llplOKB-TPCAkU2hUtDe5F9SpVAUcvAnZHXy6evHU1a3XGARkNqGpRCjDTqbIQ8qiwiAIbY8GCmjNB7tqrmxPKsUuQpSh6HN0Q7CcIBdIVvxlBzAs_NzQtvcgcEtbjwBkKszuILb--CVtn3QMjek3VrAxcpHjttirF3JS4xyi9UcWM0Vq7m-Ie93OpcLG8dfpT-gYXeSyKRdToB_uepf7l_-1ZB36BYOxzs0L_r62wJ0Epmz3DGGeIBtUjXkcE8Sxmncv7x1LFfnidkJcF1IeQE1NuTN7jJqYu3bmKdrlEHSPmV515Bni0PuuiRsIRgSL_5HV1-Se10ZIpq14pAcgPfkVwC5NuF1GV0_AaTPKPg priority: 102 providerName: Directory of Open Access Journals – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3di9QwEA96gvgifls9JYLgg4RrmzQfT3KKxyGcTy7sW8hX5WBp97bryf0795c6k83uuQr30od2Jm2ZyXwkk98Q8j5qZXodaxYdXATnnvkGV8S06L3S3LW5qvLsuzydiW_zbl4W3KZSVrm1idlQxzHgGvkRB8cGyQH410_LC4Zdo3B3tbTQuEvuIXQZarWa7xKuRunabA_KaHk0wQCqZeCVGKiuqFm354wyZv__lvmfeDP7nZNH5GEJGOnxRsKPyZ00PCH3z8qW-FNyPQNLRl04j3Q90lxtfD7QLFfqJuroMF6mBV2ukAMSbApRKg2IW-BWV3RajL9pjxes9UI0hnGgwF_gVieK67Q0bBB0_2IrOAfUDRFeMLDRFyDay3RDlctFIRN_RmYnX398OWWl8QILEK-tWfQhGK-S7lMvEw8QNoSm9lqIILRD6apamzrJGGrphfJ9k4Lpua4h-PLJ8OfkAN6dXhLapBbEbrD9BARercZ93M55J5XpvBKpIs1WAjYUVHJsjrGwOTvR0m6kZkFqNkvNdhX5uONZbjA5bqX-jILdUSKedr4xrn7aMj0tj62LDSgtD040MTrVmBBkK7ooozB1RT6gWlic9fB5wZXDC_CTiJ9lj9HRQ_AmZEUO9yhhtob9x1vFssVaTPZGtyvybvcYObECbkjjL6RB6D5p6rYiLzYKufslbjLMEH91--CvyYM2K79iDT8kB6AX6Q2EVGv_Ns-bP1DUH8o priority: 102 providerName: ProQuest |
Title | Uric acid to albumin ratio as a novel predictor for coronary slow flow phenomenon in patients with chronic coronary syndrome and non-obstructive coronary arteries |
URI | https://www.ncbi.nlm.nih.gov/pubmed/39003493 https://www.proquest.com/docview/3091289389 https://www.proquest.com/docview/3079956902 https://doaj.org/article/3d2ad1f8d3ca41dda719cc6245d6d490 |
Volume | 24 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3da9swEBf9gLGXse-564IGgz0Mb5YlW9LDGM1oKYOUURYIexH6cikEu0uydv139pfuTnHSZSt90YN9Z8W5O-kn6fw7Qt4EJXWjQpEHC43g3OWO4Y6YEo2TitsyZVWOTurjsfgyqSZbZFXuqP8D57cu7bCe1Hg2ff_rx_UnCPiPKeBV_WEOY6wsc5htcnBJUeTVNtmFmUliRYORuDlVkCqlfDAYkHOAHWz1Ec2tz9iYqBKf__-j9j9YNM1JRw_Jgx5M0oOl9R-Rrdg-JvdG_XH5E_J7DKMctf480EVHUybyeUuTzamdU0vb7jJO6cUMNWDxTQHBUo-cBnZ2TefT7oo22GAeGDI1dC0F_Z6KdU5xD5f6JbvuX2o9BwK1bYAO2rxzPUntZbyRSqmksEp_SsZHh98-H-d9UYbcA5Zb5MF5r52MqolNHbkHSOFZ4ZQQXiiLlpeF0kWsgy9qJ6RrWPS64aoAYOai5s_IDvQdXxDKYgkuobE0BYCyUuEZb2WdraWunBQxI2xlAeN7xnIsnDE1aeWiarO0mgGrmWQ1U2Xk3VrnYsnXcaf0EA27lkSu7XShm52ZPnQND6UNDByaeytYCFYy7X1diirUQegiI2_RLQz6KPw8b_sPG-AlkVvLHCAIAGAn6ozsb0hCJPvN2yvHMqtAMBwAHSyKAVdm5PX6Nmpidlwbu58og7R-tS7KjDxfOuT6lbhOFER87-6-X5L7ZXJ-mTO-T3bAL-IrgFsLNyDbciIHZHd4ePL1dJA2LQYprqA9HX7_A7_gKOU |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELaqIgEXxJtAASOBOKCoTuLEzgGh8qi2tNtTV9qb8Suo0ipZNkur_h1-AL-RGedRFqTeeskhGSeO5m2PvyHktZOirKRjsdNw4VlmYpPgipjklREy02moqpweF5MZ_zrP51vk93AWBssqB5sYDLVrLK6R72bg2CA5AP_6Yfkjxq5RuLs6tNDoxOLQX5xDyta-P_gM_H2TpvtfTj5N4r6rQGwhGFnHzlhbGuFl5avCZxZ8ok2YkZxbLjVOXTBZMl84ywrDhakSb8sqkwwiC-MRfAlM_g1wvAyTPTEfE7xESFYOB3NksdvChEUagxeMQVU4i_MN5xd6BPzvCf6Jb4Of279L7vQBKt3rJOoe2fL1fXJz2m_BPyC_ZmA5qbanjq4bGqqbT2sa5IjqlmpaN2d-QZcrHAEJPYWomFrESdCrC9oumnNa4QVryxD9oakpjO_hXVuK68LUdoi9fw3rcRWorh18oI4b0wPfnvlLqlCeCpn_QzK7FpY8Itvwbf-E0MSnIGYltruAQC-VuG-ca6MLUeZGcB-RZOCAsj0KOjbjWKiQDclCdVxTwDUVuKbyiLwbxyw7DJArqT8iY0dKxO8ON5rVd9WbA5W5VLsElCSzmifOaZGU1hYpz13heMki8hbFQqGVgelZ3R-WgJ9EvC61h4EFBIu8iMjOBiVYB7v5eBAs1VunVl3qUkRejY9xJFbc1b75iTQIFViULI3I404gx1_KygBrlD29-uUvya3JyfRIHR0cHz4jt9OgCCJOsh2yDTLin0M4tzYvgg5R8u26lfYPNK5dvQ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Uric+acid+to+albumin+ratio+as+a+novel+predictor+for+coronary+slow+flow+phenomenon+in+patients+with+chronic+coronary+syndrome+and+non-obstructive+coronary+arteries&rft.jtitle=BMC+cardiovascular+disorders&rft.au=Zhang%2C+Xiao-jiao&rft.au=Hou%2C+Ai-jie&rft.au=Luan%2C+Bo&rft.au=Wang%2C+Cheng-fu&rft.date=2024-07-13&rft.pub=BioMed+Central+Ltd&rft.issn=1471-2261&rft.eissn=1471-2261&rft.volume=24&rft.issue=1&rft_id=info:doi/10.1186%2Fs12872-024-04040-5&rft.externalDocID=A801266346 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2261&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2261&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2261&client=summon |